228 related articles for article (PubMed ID: 37420249)
21. DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations.
Yuan Y; Shi Y; Li C; Kim J; Cai W; Han Z; Feng DD
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):476. PubMed ID: 28155641
[TBL] [Abstract][Full Text] [Related]
22. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
23. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
24. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.
Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I
BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674
[TBL] [Abstract][Full Text] [Related]
25. Multiple-instance learning of somatic mutations for the classification of tumour type and the prediction of microsatellite status.
Anaya J; Sidhom JW; Mahmood F; Baras AS
Nat Biomed Eng; 2024 Jan; 8(1):57-67. PubMed ID: 37919367
[TBL] [Abstract][Full Text] [Related]
26. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Chalmers ZR; Connelly CF; Fabrizio D; Gay L; Ali SM; Ennis R; Schrock A; Campbell B; Shlien A; Chmielecki J; Huang F; He Y; Sun J; Tabori U; Kennedy M; Lieber DS; Roels S; White J; Otto GA; Ross JS; Garraway L; Miller VA; Stephens PJ; Frampton GM
Genome Med; 2017 Apr; 9(1):34. PubMed ID: 28420421
[TBL] [Abstract][Full Text] [Related]
27. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
[TBL] [Abstract][Full Text] [Related]
28. NetNorM: Capturing cancer-relevant information in somatic exome mutation data with gene networks for cancer stratification and prognosis.
Le Morvan M; Zinovyev A; Vert JP
PLoS Comput Biol; 2017 Jun; 13(6):e1005573. PubMed ID: 28650955
[TBL] [Abstract][Full Text] [Related]
29. Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer.
Nero C; Boldrini L; Lenkowicz J; Giudice MT; Piermattei A; Inzani F; Pasciuto T; Minucci A; Fagotti A; Zannoni G; Valentini V; Scambia G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232628
[TBL] [Abstract][Full Text] [Related]
30. A pan-cancer somatic mutation embedding using autoencoders.
Palazzo M; Beauseroy P; Yankilevich P
BMC Bioinformatics; 2019 Dec; 20(1):655. PubMed ID: 31829157
[TBL] [Abstract][Full Text] [Related]
31. Identification of 12 cancer types through genome deep learning.
Sun Y; Zhu S; Ma K; Liu W; Yue Y; Hu G; Lu H; Chen W
Sci Rep; 2019 Nov; 9(1):17256. PubMed ID: 31754222
[TBL] [Abstract][Full Text] [Related]
32. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
33. Divergent mutational processes distinguish hypoxic and normoxic tumours.
Bhandari V; Li CH; Bristow RG; Boutros PC;
Nat Commun; 2020 Feb; 11(1):737. PubMed ID: 32024819
[TBL] [Abstract][Full Text] [Related]
34. APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.
Jakobsdottir GM; Brewer DS; Cooper C; Green C; Wedge DC
BMC Biol; 2022 May; 20(1):117. PubMed ID: 35597990
[TBL] [Abstract][Full Text] [Related]
35. Cancer subtype identification using somatic mutation data.
Kuijjer ML; Paulson JN; Salzman P; Ding W; Quackenbush J
Br J Cancer; 2018 May; 118(11):1492-1501. PubMed ID: 29765148
[TBL] [Abstract][Full Text] [Related]
36. Universal encoding of pan-cancer histology by deep texture representations.
Komura D; Kawabe A; Fukuta K; Sano K; Umezaki T; Koda H; Suzuki R; Tominaga K; Ochi M; Konishi H; Masakado F; Saito N; Sato Y; Onoyama T; Nishida S; Furuya G; Katoh H; Yamashita H; Kakimi K; Seto Y; Ushiku T; Fukayama M; Ishikawa S
Cell Rep; 2022 Mar; 38(9):110424. PubMed ID: 35235802
[TBL] [Abstract][Full Text] [Related]
37. A machine learning approach for somatic mutation discovery.
Wood DE; White JR; Georgiadis A; Van Emburgh B; Parpart-Li S; Mitchell J; Anagnostou V; Niknafs N; Karchin R; Papp E; McCord C; LoVerso P; Riley D; Diaz LA; Jones S; Sausen M; Velculescu VE; Angiuoli SV
Sci Transl Med; 2018 Sep; 10(457):. PubMed ID: 30185652
[TBL] [Abstract][Full Text] [Related]
38. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
[TBL] [Abstract][Full Text] [Related]
39. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
40. Ensemble-Based Somatic Mutation Calling in Cancer Genomes.
Huang W; Guo YA; Chang MM; Skanderup AJ
Methods Mol Biol; 2020; 2120():37-46. PubMed ID: 32124310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
